632 related articles for article (PubMed ID: 15983219)
21. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
Raats CJ; Van Den Born J; Berden JH
Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
[TBL] [Abstract][Full Text] [Related]
22. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
[TBL] [Abstract][Full Text] [Related]
23. The role of heparanase in diseases of the glomeruli.
Szymczak M; Kuźniar J; Klinger M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
[TBL] [Abstract][Full Text] [Related]
24. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of heparanase in overt diabetic nephropathy.
van den Hoven MJ; Rops AL; Bakker MA; Aten J; Rutjes N; Roestenberg P; Goldschmeding R; Zcharia E; Vlodavsky I; van der Vlag J; Berden JH
Kidney Int; 2006 Dec; 70(12):2100-8. PubMed ID: 17051139
[TBL] [Abstract][Full Text] [Related]
26. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
27. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium.
Yard BA; Kahlert S; Engelleiter R; Resch S; Waldherr R; Groffen AJ; van den Heuvel LP; van der Born J; Berden JH; Kröger S; Hafner M; van der Woude FJ
Exp Nephrol; 2001; 9(3):214-22. PubMed ID: 11340306
[TBL] [Abstract][Full Text] [Related]
28. Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria.
Garsen M; Rops AL; Li J; van Beneden K; van den Branden C; Berden JH; Rabelink TJ; van der Vlag J
PLoS One; 2016; 11(8):e0160894. PubMed ID: 27505185
[TBL] [Abstract][Full Text] [Related]
29. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
[TBL] [Abstract][Full Text] [Related]
30. Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats.
Heeringa P; Van den Born J; Brouwer E; Dolman KM; Klok PA; Huitema MG; Limburg PC; Bakker MA; Berden JH; Daha MR; Kallenberg CG
Clin Exp Immunol; 1996 Aug; 105(2):321-9. PubMed ID: 8706341
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
[TBL] [Abstract][Full Text] [Related]
32. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
[TBL] [Abstract][Full Text] [Related]
33. A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.
Masola V; Onisto M; Zaza G; Lupo A; Gambaro G
J Transl Med; 2012 Oct; 10():213. PubMed ID: 23095131
[TBL] [Abstract][Full Text] [Related]
34. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
[TBL] [Abstract][Full Text] [Related]
35. Heparanase is essential for the development of diabetic nephropathy in mice.
Gil N; Goldberg R; Neuman T; Garsen M; Zcharia E; Rubinstein AM; van Kuppevelt T; Meirovitz A; Pisano C; Li JP; van der Vlag J; Vlodavsky I; Elkin M
Diabetes; 2012 Jan; 61(1):208-16. PubMed ID: 22106160
[TBL] [Abstract][Full Text] [Related]
36. Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
J Am Soc Nephrol; 2004 Jan; 15(1):68-78. PubMed ID: 14694159
[TBL] [Abstract][Full Text] [Related]
37. [Expression of heparanase in kidney of rats with respiratory syncytial virus nephropathy and its relationship with proteinurina].
Tao YH; Wang Z; Zhou YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):212-5, 224. PubMed ID: 24749342
[TBL] [Abstract][Full Text] [Related]
38. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis.
Patel VN; Knox SM; Likar KM; Lathrop CA; Hossain R; Eftekhari S; Whitelock JM; Elkin M; Vlodavsky I; Hoffman MP
Development; 2007 Dec; 134(23):4177-86. PubMed ID: 17959718
[TBL] [Abstract][Full Text] [Related]
39. The effect of aminoguanidine on urinary heparan sulphate levels in experimental diabetes.
Unlüçerçi YM; Bekpinar S; Seferoglu G
Acta Diabetol; 2000; 37(2):71-6. PubMed ID: 11194930
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy.
Makino H; Yamasaki Y; Haramoto T; Shikata K; Hironaka K; Ota Z; Kanwar YS
Lab Invest; 1993 Jan; 68(1):45-55. PubMed ID: 8423676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]